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Background: A modelling analysis carried out in 2014 suggested that, without cervical cancer screening pro-
grammes, the incidence of cervical cancer in Denmark, Finland, Norway and Sweden would have been as high
as that in some low- and middle-income countries. We compare programme strategies between Nigeria and
these Nordic countries and develop translatable recommendations.
Methods: A literature review using a systematic approach throughMedline, Popline, Global Health, CINAHL PLUS,
Cochrane Library, EMBASE, Google Scholar, Africa Wide and WHO databases was conducted.
Results: Fifteen journal articles and two grey literature reports met our criteria. Six descriptive studies from
Nigeria noted that services in Nigeria weremainly provided in urban secondary/tertiary facilities and that uptake
was low even where screening was free. Trials in Nigeria and Sweden noted that subsidies and free programmes
alone did not improve uptake; a Danish trial demonstrated that reminders and invitations issued by general
practitioners improved participation.
Conclusion: Free screening programmes are important but should also consider incentivisation of treatment
when needed and demand creation among health workers. Additionally, effective monitoring and evaluation of
programme data are key to improving and maintaining quality. More broadly, we suggest that Nigeria can build
success through stakeholder-led implementation of well-defined policies with national consensus to ensure
coordination and sustainability.
Keywords: cervical cancer, Nigeria, prevention and control, public health systems research, review, Scandinavian and Nordic countries.
Introduction
Cervical cancer is a disease of great public health interest be-
cause it is easily preventable and primarily affects women aged
15–44 y, an age group within which women make great social
and economic contributions.1 The main cause of cervical can-
cer is persistent infection with HPV, which is sexually transmit-
ted; precancerous lesions develop over 5–10 y, from which in-
vasive cervical cancer can develop decades later.2 In Nigeria,
70 327 deaths in women were attributed to cancer, with cer-
vical cancer causing 14.8% of those deaths in 2018, making it
the second most common cancer after breast cancer.3 A fre-
quent occurrence in Nigeria is a trend of late presentation and
diagnosis at advanced stages of the disease leading to poor
prognosis.4,5
About 118 million women have been immunised against HPV,
ofwhich only 1%are from low- tomiddle-income countries,6 with
numerous barriers reported.7,8
In some developed countries a marked reduction in cervical
cancer incidence has been noted through organised screening
programmes, with adoption of national screening algorithms and
guidelines.9–14 Time trends were used to ascertainmortality from
cervical cancer following the advent of screening programmes
since the early 1950s in Denmark, Finland, Iceland, Norway and
Sweden; the authors reported that in these five countries mor-
tality rates fell by 10–80%.15 More recently, a modelling analy-
sis of cervical cancer screening programmes in four countries in
the Nordic region (Denmark, Finland, Norway and Sweden), using
ad hoc-refined age-period-cohort models, suggested that cervi-
cal cancer incidence rates in the Nordic countries would ‘have
© The Author(s) (2020). Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. This is an Open
Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which
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been otherwise comparable to the highest incidence rates cur-
rently detected in low-income countries’ if not for their cancer
prevention programmes.10
Existing studies in the broader literature relates cervical cancer
screening gaps to high incidence in Nigeria, highlighting determi-
nants of low screening rates such as poor awareness of screen-
ing services16,17 and psychosocial factors like poor risk perception
and fear of positive results.18,19 In another study, screening gaps
were attributed to demand-side barriers like cost and the non-
availability of local screening services.20 These, and similar stud-
ies,16–19,21,22 provide a basis for proposing solutions and charting
a course forward towards progress.
Aim and Objectives
Our aim is to assess the current state of cervical cancer preven-
tion strategies in Nigeria and compare this with evidence-based
interventions that are/were implemented in the four Nordic coun-
tries of interest, namely, Denmark, Finland, Norway and Sweden,
to highlight relevant lessons learned for the Nigerian context.
The specific objectives are to:
1. Ascertain how cervical cancer prevention services are/were
implemented in Nigeria and across the four selected Nordic
countries by considering method of delivery (opportunistic vs
organised) and the availability of services at rural and urban
health facilities.
2. Assess the effect of targeted interventions onwomen’s uptake
of services.
3. Investigate potential factors said to be responsible for the de-
cline in cervical cancer incidence in these Nordic countries and
to seek relevant lessons learned for implementation in Nigeria,
discussing context-specific limitations to generalisability.
Through this reviewwe intend to broaden the prior knowledge
base by seeking how interventions are currently implemented
across all these countries and what was/is being done to improve
implementation. In looking holistically at these systems, we will
consider both demand- and supply-side factors that help or hin-
der intervention strategies. In addition, our review will add to the
earlier work of others through our novel cross-continent compari-
son, inwhichwe seek common themes arising in theNordic coun-
tries and explore the feasibility of these to serve as a model for
Nigeria or to influence future innovations.
Materials and Methods
Our review follows the PRISMA guidelines and checklist (see Ap-
pendix 1 in the Supplementary Data file).23
Literature searches
Published peer-reviewed journal articles and studies on cervical
cancer prevention and control programmes in the selected coun-
tries were obtained by conducting database searches in Ovid
Medline, Popline, Global Health, CINAHL PLUS, Cochrane Library
and EMBASE. Searches were undertaken in all the databases
using a combination of MeSH terms and free text. Appendix 2 in
the Supplementary Data file shows the search concepts and syn-
onyms that were then joined with Boolean operators to form the
following search string of concepts (into which their synonyms
were added): ‘Cervical Cancer* AND Cancer screen* AND (Nige-
ria OR Nordic Countries)’. Grey literature was sought using Google
Scholar, Africa Wide and WHO databases. To refine searches in
Google, keywords were used in addition to the URL of interest
(e.g. ‘cervical cancer screening Nigeria who.int’).
Articles were limited to those written in English and/or trans-
lated to English. Date limits were set to start at the year 2000. The
dates of initial database searches for papers reviewed are as fol-
lows: Africa Wide on 26 June 2018, PopLine, MedLine and Global
Health on 25 July 2018, CINAHL PLUS, Cochrane Library and Em-
base on 26 July 2018 and Google Search on 28 July 2018. To en-
sure no more recent publication was missed, database searches
were repeated on the following dates: MedLine on 21 October
2019, Africa Wide, Global Health, CINAHL PLUS, Cochrane Library
and Embase and Google Scholar on 5 November 2019. (Popline
was retired on 1 September 2019, so we were unable to rerun
searches there.) The complete search strategies are available in
Appendix 3 of the Supplementary Data file.
Limits and selection criteria
Studies were included only if they had information about cervical
cancer prevention programmes administered by governmental
or non-governmental institutions, private institutions or interna-
tional organisations in the countries of interest, either as a stand-
alone programme or as part of an integrated package of care.
Only secondary prevention is being considered in this review so
the methods for early cancer diagnosis were limited to visual in-
spection with acetic acid, visual inspection with lugol iodine, test
and treat, HPV testing and pap smear.
Data extraction and quality assessment
Relevant data from the selected studies were extracted into a
table to facilitate the review process. Studies were assessed for
quality guided by NIH quality assessment tools (QAT) for con-
trolled intervention, observational and cohort studies.24 The pa-
pers were appraised on whether the aims were clearly and logi-
cally specified, themethodologywas appropriate to the aims and
if the study populations were well defined. Studies were assessed
based on the number of affirmative responses to the QAT criteria
and classified into ratings of good, fair or poor. The cut-off point
for the ratings are described in National Heart, Lung, and Blood
Institute’s quality assessment tools.24
For the WHO reports obtained from grey literature searches,
the quality was authenticated using The Sheridan Libraries at
Johns Hopkins University open source guide and template for
evaluating data sources from the internet using the acronym
CRAAP: Is it Current enough, Relevance, Authority? What makes
me trust the information, Accuracy, and Purpose?25 The parame-
ter ‘Relevance’ was removed as the inclusion/exclusion criteria al-
ready accounts for this. The sample data extraction form, critical
appraisal tools and tables for all the academic and grey literature
can be found in Supplementary Data file (Appendices 4–7)
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Figure 1. PRISMA23 diagram.
Results
Summary of articles and reports included in the review
A total of 2051 non-duplicated publications were identified for
screening, with 1975 being screened out through title or abstract
alone. The full texts for the other 76 articles were obtained and
reviewed. Of the 76 full-text publications assessed for eligibility,
we excluded 59 publications for one or both of the following
reasons: (1) little or no information provided about the imple-
mentation of cervical cancer prevention programmes; (2) the
focus of the paperwas cervical cancer prevention via primary pre-
vention (HPV vaccination) rather than secondary prevention. This
process resulted in 17 publications thatmet the selection criteria.
Figure 123 shows details of records identified, screened, included
and
excluded.
Fifteen journal articles and two grey literature items were in-
cluded in the review having met the selection criteria. These
articles were diverse with six descriptive studies26–31 (includ-
ing one that was population-based31), one randomised exper-
imental study,32 two population-based cluster randomised tri-
als,33,34 one cohort study,10 five articles involving secondary data
analyses35–39 and two reports.40,41 Six of the academic studies
published in journals were set in Nigeria and nine were from the
Nordic countries of interest (Table 1). The WHO report describes
the outcomes of cervical cancer pilot projects in six African coun-
tries including Nigeria.40 The second report is on the status of
implementation of cancer-screening programmes in the Euro-
pean Union, of which three of the four countries of interest were
discussed.41
Quality assessment
Fifteen journal articles were assessed using the QAT criteria. Of
the articles selected, two were rated as ‘low’ because (1) small
sample sizes were selected without clear description of their
methodological design, which restricted generalisability to the
general population, (2) we were unable to confirm if biases and
confounding factors were sufficiently considered from the in-
formation provided and (3) we were not able to ascertain eth-
ical consideration from the information provided.27,30 Two pa-
pers were rated as ‘fair’ because the methodological design was
not adequately described to give information on sample selec-
tion and study duration.26,28 None of these papers were excluded
3
D
ow
nloaded from
 https://academ
ic.oup.com
/inthealth/advance-article/doi/10.1093/inthealth/ihaa062/5916400 by guest on 23 O
ctober 2020
International Health
Ta
bl
e
1.
Su
m
m
ar
y
of
st
ud
y
ch
ar
ac
te
ris
tic
s
fo
ra
rt
ic
le
s/
re
po
rt
s
in
cl
ud
ed
in
th
e
re
vi
ew
Au
th
or
s
St
ud
y
ch
ar
ac
te
ris
tic
s
O
ut
co
m
es
re
po
rt
ed
by
au
th
or
s
Au
th
or
s’
co
nc
lu
si
on
s
Jo
ur
na
la
rt
ic
le
s
in
N
ig
er
ia
n
se
tt
in
gs
(in
cl
ud
in
g
re
vi
ew
s)
Ba
ss
ey
et
al
(2
00
8)
30
De
sc
rip
tiv
e
st
ud
y
Po
or
up
ta
ke
of
se
rv
ic
es
Th
er
e
ar
e
no
or
ga
ni
se
d
ce
rv
ic
al
ca
nc
er
sc
re
en
in
g
pr
og
ra
m
m
es
al
th
ou
gh
th
er
e
ar
e
fa
ci
lit
ie
s
fo
rc
yt
ol
og
y
in
so
m
e
N
ig
er
ia
n
ho
sp
ita
ls
,w
hi
ch
se
rv
e
a
lim
ite
d
nu
m
be
ro
fw
om
en
Ch
uk
w
ua
li
et
al
(2
00
3)
28
De
sc
rip
tiv
e
st
ud
y
Po
or
up
ta
ke
of
se
rv
ic
es
:o
nl
y
81
5
w
om
en
pa
rt
ic
ip
at
ed
in
th
e
hi
gh
ly
su
bs
id
is
ed
sc
re
en
in
g
se
rv
ic
e
in
En
ug
u
ov
er
a
10
-y
pe
rio
d
Du
e
to
re
as
on
s
su
ch
as
po
or
aw
ar
en
es
s
an
d
so
ci
oc
ul
tu
ra
l
ba
rr
ie
rs
,s
ub
si
di
se
d
ce
rv
ic
al
ca
nc
er
sc
re
en
in
g
w
as
no
t
ad
eq
ua
te
ly
ut
ili
se
d
Ad
ep
oj
u
et
al
(2
01
6)
26
De
sc
rip
tiv
e
st
ud
y
Ch
al
le
ng
es
to
ac
ce
ss
in
g
ce
rv
ic
al
ca
nc
er
sc
re
en
in
g:
di
sp
ar
ity
of
lo
ca
tio
n
in
fa
vo
ur
of
ur
ba
n
te
rt
ia
ry
fa
ci
lit
ie
s,
lo
w
ris
k
pe
rc
ep
tio
n
an
d
lo
gi
st
ic
al
is
su
es
in
ru
ra
la
re
as
Si
nc
e
m
os
tp
ar
tic
ip
an
ts
w
er
e
ur
ba
n-
ba
se
d,
th
er
e
is
ne
ed
to
de
ce
nt
ra
lis
e
ca
nc
er
of
ce
rv
ix
sc
re
en
in
g
th
ro
ug
h
m
ob
ile
cl
in
ic
s
an
d
es
ta
bl
is
hm
en
to
fs
cr
ee
ni
ng
ce
nt
re
s
in
th
e
ru
ra
la
re
as
O
bi
et
al
(2
00
7)
27
De
sc
rip
tiv
e
st
ud
y
Po
or
pa
rt
ic
ip
at
io
n
as
<
1%
(9
32
w
om
en
)o
ft
ar
ge
t
po
pu
la
tio
n
pa
rt
ic
ip
at
ed
It
w
as
no
te
no
ug
h
to
pr
ov
id
e
ce
rv
ic
al
ca
nc
er
sc
re
en
in
g
se
rv
ic
es
bu
tt
he
re
is
a
ne
ed
to
fo
llo
w
up
th
es
e
se
rv
ic
es
by
su
st
ai
ne
d
aw
ar
en
es
s
ca
m
pa
ig
ns
an
d
m
ot
iv
at
io
n
of
he
al
th
ca
re
pr
ov
id
er
s
to
of
fe
ra
pp
ro
pr
ia
te
in
fo
rm
at
io
n
to
pa
tie
nt
s
N
na
di
et
al
(2
01
6)
29
De
sc
rip
tiv
e
st
ud
y
Pa
rt
ic
ip
at
io
n
w
as
ex
tr
em
el
y
po
or
co
m
pa
re
d
w
ith
si
m
ila
r
st
ud
ie
s
co
nd
uc
te
d
in
ot
he
rp
ar
ts
of
th
e
co
un
tr
y.
In
di
ca
tio
n
fo
rc
er
vi
ca
ls
cr
ee
ni
ng
w
as
m
os
tly
sy
m
pt
om
-b
as
ed
re
fe
rr
al
s
fro
m
fa
ci
lit
ie
s
w
ith
ou
t
sc
re
en
in
g
se
rv
ic
es
w
ith
in
an
d
ou
ts
id
e
th
e
st
at
e
O
nl
y
th
ro
ug
h
fo
rm
ul
at
io
n
an
d
im
pl
em
en
ta
tio
n
of
an
or
ga
ni
se
d
na
tio
na
ls
cr
ee
ni
ng
pr
og
ra
m
m
e
(w
hi
le
m
ax
im
is
in
g
op
po
rt
un
is
tic
sc
re
en
in
g
in
th
e
in
te
rim
)c
an
sc
re
en
in
g
be
pe
rf
or
m
ed
m
or
e
ef
fe
ct
iv
el
y
an
d
ef
fic
ie
nt
ly
O
ke
ke
et
al
(2
01
2)
32
Ra
nd
om
iz
ed
ex
pe
rim
en
ta
l
st
ud
y
Ba
rr
ie
rs
to
ac
ce
ss
in
cl
ud
e
di
st
an
ce
an
d
tr
av
el
co
st
s;
w
om
en
w
ho
w
er
e
ra
nd
om
ly
se
le
ct
ed
to
re
ce
iv
e
th
e
co
nd
iti
on
al
ca
nc
er
tr
ea
tm
en
ts
ub
si
dy
w
er
e
ab
ou
t4
%
m
or
e
lik
el
y
to
ac
ce
pt
ce
rv
ic
al
ca
nc
er
sc
re
en
in
g
Th
e
op
tim
al
se
to
fs
ub
si
di
es
sh
ou
ld
in
cl
ud
e
tr
ea
tm
en
t
su
bs
id
ie
s
(if
th
e
cl
ie
nt
is
sc
re
en
ed
po
si
tiv
e)
in
ad
di
tio
n
to
sc
re
en
in
g
pr
ic
e
su
bs
id
ie
s
Al
fo
nz
o
et
al
(2
01
6)
33
Po
pu
la
tio
n-
ba
se
d
ra
nd
om
iz
ed
co
nt
ro
lle
d
tr
ia
l
Pa
rt
ic
ip
at
io
n
w
as
no
ta
ffe
ct
ed
by
th
e
ab
se
nc
e
or
pr
es
en
ce
of
a
fe
e
O
th
er
st
ra
te
gi
es
co
ul
d
be
em
pl
oy
ed
in
so
ci
al
ly
di
sa
dv
an
ta
ge
d
ur
ba
n
di
st
ric
ts
as
ab
ol
is
hi
ng
fe
es
di
d
no
ti
nc
re
as
e
at
te
nd
an
ce
in
th
e
sh
or
tt
er
m
Jo
ur
na
la
rt
ic
le
s
in
N
or
di
c
se
tt
in
gs
(in
cl
ud
in
g
re
vi
ew
s)
Je
ns
en
et
al
34
(2
00
9)
Cl
us
te
rr
an
do
m
iz
ed
co
nt
ro
lle
d
tr
ia
l
Im
pr
ov
ed
pa
rt
ic
ip
at
io
n
an
d
im
pr
ov
ed
co
ve
ra
ge
w
he
n
w
om
en
w
er
e
ta
rg
et
ed
w
ith
in
vi
ta
tio
ns
an
d
en
ha
nc
em
en
to
fG
Ps
’a
tt
en
tio
n
to
ce
rv
ic
al
ca
nc
er
pr
og
ra
m
m
es
in
De
nm
ar
k
U
si
ng
a
sp
ec
ia
lt
ar
ge
te
d
in
vi
ta
tio
n
to
no
n-
at
te
nd
ee
s
co
m
bi
ne
d
w
ith
in
cr
ea
si
ng
GP
s’
at
te
nt
io
n
to
th
e
pr
og
ra
m
m
es
co
ul
d
im
pr
ov
e
w
om
en
’s
pa
rt
ic
ip
at
io
n
an
d
in
cr
ea
se
co
ve
ra
ge
of
ce
rv
ic
al
ca
nc
er
sc
re
en
in
g
El
fs
tr
om
et
al
(2
01
6)
31
Po
pu
la
tio
n-
ba
se
d
de
sc
rip
tiv
e
st
ud
y
An
al
ys
in
g
ke
y
qu
al
ity
in
di
ca
to
rs
fo
rm
ed
th
e
ba
si
s
fo
r
qu
al
ity
im
pr
ov
em
en
to
ft
he
or
ga
ni
se
d
ce
rv
ic
al
sc
re
en
in
g
pr
og
ra
m
m
es
in
Sw
ed
en
Re
gu
la
rr
eg
is
tr
y-
ba
se
d
m
on
ito
rin
g
an
d
ev
al
ua
tio
n
of
qu
al
ity
in
di
ca
to
rs
ca
n
pr
ov
id
e
an
ev
id
en
ce
ba
se
fo
r
pr
io
rit
is
at
io
n
of
im
pr
ov
em
en
ts
tr
at
eg
ie
s
Va
cc
ar
el
la
et
al
(2
01
6)
44
Co
ho
rt
st
ud
y
In
th
e
ab
se
nc
e
of
sc
re
en
in
g,
in
ci
de
nc
e
ra
te
s
fo
r
20
06
–2
01
0
in
N
or
di
c
co
un
tr
ie
s
w
ou
ld
ha
ve
be
en
fiv
ef
ol
d
hi
gh
er
th
an
ob
se
rv
ed
ra
te
s
Th
e
or
ga
ni
se
d
sc
re
en
in
g
pr
og
ra
m
s
in
th
es
e
fo
ur
N
or
di
c
co
un
tr
ie
s
ha
ve
re
su
lte
d
in
th
e
lo
w
in
ci
de
nc
e
of
ce
rv
ic
al
ca
nc
er
Di
lln
er
(2
00
0)
35
Re
vi
ew
ar
tic
le
Ce
rv
ic
al
ca
nc
er
sc
re
en
in
g
in
Sw
ed
en
is
he
te
ro
ge
ne
ou
s
in
qu
al
ity
,i
.e
.s
om
e
co
un
tie
s
pr
ac
tis
e
or
ga
ni
se
d
sc
re
en
in
g
an
d
ot
he
rs
ar
e
op
po
rt
un
is
tic
M
or
e
st
ud
ie
s
ne
ed
to
be
co
nd
uc
te
d
to
as
se
ss
th
e
ef
fe
ct
of
or
ga
ni
se
d
sc
re
en
in
g
vs
sp
on
ta
ne
ou
s
sc
re
en
in
g
on
ce
rv
ic
al
ca
nc
er
m
or
ta
lit
y
4
D
ow
nloaded from
 https://academ
ic.oup.com
/inthealth/advance-article/doi/10.1093/inthealth/ihaa062/5916400 by guest on 23 O
ctober 2020
International Health
Ta
bl
e
1.
Co
nt
in
ue
d
Au
th
or
s
St
ud
y
ch
ar
ac
te
ris
tic
s
O
ut
co
m
es
re
po
rt
ed
by
au
th
or
s
Au
th
or
s’
co
nc
lu
si
on
s
H
or
tlu
nd
et
al
(2
01
8)
39
Re
se
ar
ch
ar
tic
le
22
78
00
0
ce
rv
ic
al
sa
m
pl
es
co
lle
ct
ed
in
Sw
ed
en
in
20
14
–2
01
6
w
ith
69
%
co
m
in
g
fro
m
th
e
or
ga
ni
se
d
sc
re
en
in
g
pr
og
ra
m
m
e.
Sc
re
en
in
g
co
ve
ra
ge
w
as
82
%
(a
n
av
er
ag
e
of
71
–9
2%
w
ith
in
co
un
tie
s)
;c
er
vi
ca
l
ca
nc
er
sh
ow
ed
an
in
cr
ea
si
ng
tr
en
d
Ke
y
qu
al
ity
in
di
ca
to
rs
su
ch
as
po
pu
la
tio
n
co
ve
ra
ge
an
d
fo
llo
w
-u
p
ra
te
s
w
er
e
st
ab
le
or
im
pr
ov
in
g,
bu
t
ne
ve
rt
he
le
ss
th
er
e
w
as
a
ce
rv
ic
al
ca
nc
er
in
cr
ea
se
su
gg
es
tin
g
th
at
cu
rr
en
te
ffo
rt
s
fo
rm
ea
su
rin
g
an
d
re
po
rt
in
g
qu
al
ity
in
di
ca
to
rs
ar
e
in
su
ffi
ci
en
t
An
tt
ila
et
al
(2
00
0)
36
Re
vi
ew
ar
tic
le
In
ci
de
nc
e
of
ce
rv
ic
al
ca
nc
er
ha
s
de
cr
ea
se
d
in
Fi
nl
an
d
an
d
th
is
is
at
tr
ib
ut
ed
to
or
ga
ni
se
d
sc
re
en
in
g
ac
tiv
iti
es
Th
e
30
-y
-o
ld
or
ga
ni
se
d
sc
re
en
in
g
pr
og
ra
m
m
es
ha
ve
re
su
lte
d
in
a
de
cr
ea
se
of
>
70
%
ce
rv
ic
al
ca
nc
er
in
ci
de
nc
e
an
d
a
re
du
ct
io
n
in
ce
rv
ic
al
ca
nc
er
m
or
ta
lit
y
N
yg
år
d
et
al
38
(2
00
2)
Re
vi
ew
ar
tic
le
Th
e
N
or
w
eg
ia
n
co
or
di
na
te
d
pr
og
ra
m
m
e
in
tr
od
uc
ed
in
19
95
co
lle
ct
ed
a
to
ta
lo
f4
74
4
96
7
pa
p
sm
ea
rs
fro
m
>
1.
4
m
ill
io
n
w
om
en
ag
ed
25
–6
9
y
re
co
m
m
en
de
d
to
ha
ve
a
co
nv
en
tio
na
lp
ap
sm
ea
re
ve
ry
3
y
Th
e
sc
re
en
in
g
pr
og
ra
m
m
e
pr
ov
id
es
a
lo
w
-c
os
tw
ay
to
in
cr
ea
se
co
ve
ra
ge
as
th
e
nu
m
be
ro
fw
om
en
w
ho
ha
d
a
pa
p
sm
ea
rw
as
hi
gh
er
af
te
ri
m
pl
em
en
ta
tio
n
of
th
e
co
or
di
na
te
d
pr
og
ra
m
m
e
of
w
om
en
ag
ed
23
–5
9
y
Bi
ga
ar
d
et
al
(2
00
0)
37
Re
vi
ew
ar
tic
le
Da
ni
sh
sc
re
en
in
g
pr
og
ra
m
m
es
ha
d
go
od
co
ve
ra
ge
as
a
to
ta
lo
f6
50
00
0
sm
ea
rs
w
er
e
ta
ke
n
an
nu
al
ly
,w
hi
ch
co
rr
es
po
nd
s
to
sc
re
en
in
g
of
al
lD
an
is
h
w
om
en
ag
ed
25
–5
9
y
on
av
er
ag
e
ev
er
y
se
co
nd
ye
ar
,e
ve
n
al
th
ou
gh
th
e
gu
id
el
in
es
re
co
m
m
en
d
sc
re
en
in
g
ev
er
y
th
ird
ye
ar
.
Th
er
e
w
as
a
de
cr
ea
se
in
in
ci
de
nc
e
fro
m
15
.3
pe
r1
00
00
0
w
om
en
du
rin
g
19
87
–1
99
2
to
12
.9
pe
r1
00
00
0
w
om
en
du
rin
g
19
93
–1
99
5
O
rg
an
is
ed
sc
re
en
in
g
ha
s
a
be
tt
er
pr
ev
en
tiv
e
ef
fe
ct
th
an
op
po
rt
un
is
tic
sc
re
en
in
g;
th
ey
re
co
m
m
en
d
a
m
ov
e
to
w
ar
ds
a
lo
ng
er
sc
re
en
in
g
in
te
rv
al
th
an
th
e
3-
y
in
te
rv
al
cu
rr
en
tly
pr
ac
tis
ed
Gr
ey
lit
er
at
ur
e
W
H
O
(2
01
2)
40
Pr
oj
ec
tr
ep
or
t
O
bs
er
va
tio
n
of
po
or
up
ta
ke
an
d
co
ve
ra
ge
in
N
ig
er
ia
Th
er
e
is
a
ne
ed
fo
re
ffe
ct
iv
e
m
on
ito
rin
g
an
d
ev
al
ua
tio
n
sy
st
em
to
tr
ac
k
ke
y
pe
rf
or
m
an
ce
in
di
ca
to
rs
su
ch
as
co
ve
ra
ge
an
d
in
ci
de
nc
e
Po
nt
ie
ta
l(
20
17
)4
1
M
ee
tin
g
re
po
rt
Th
e
Fi
nn
is
h
pr
og
ra
m
m
e
ha
s
pr
ov
en
to
be
ve
ry
ef
fe
ct
iv
e
in
re
du
ci
ng
th
e
in
ci
de
nc
e
of
an
d
m
or
ta
lit
y
fro
m
ce
rv
ic
al
ca
nc
er
Th
e
Fi
nn
is
h
ce
rv
ic
al
ca
nc
er
sc
re
en
in
g
pr
og
ra
m
m
e
is
an
ex
am
pl
e
of
a
co
st
-e
ffe
ct
iv
e
w
ay
to
ru
n
an
or
ga
ni
se
d
pr
og
ra
m
m
e
5
D
ow
nloaded from
 https://academ
ic.oup.com
/inthealth/advance-article/doi/10.1093/inthealth/ihaa062/5916400 by guest on 23 O
ctober 2020
International Health
from the review but these limitations should be kept in mind
when interpreting the findings.
Cervical cancer screening in Nigeria and the Nordic
countries of interest: method of delivery and
availability of services at rural and urban health
facilities
Method of delivery
In both Nigerian and Nordic settings, the authors attempt to ex-
plain achievements (or gaps) in the screening programmes by
considering the nature of screening (i.e. opportunistic vs orga-
nized). The International Agency for Research on Cancer defines
opportunistic screening as ‘early detection of cancer performed
in a diagnostic or clinical context or performed often in a prophy-
lactic purpose’.41 For cervical cancer-screening programmes to be
considered organised theymust have the following: (1) clear poli-
cies that specify the target population, the type of screening tests
and screening intervals; (2) public funding; (3) a system for invit-
ing women for screening; (4) a team responsible for overseeing
programme implementation; and (5) structures to ensure quality
improvement.41 This definition clarifies findings across the litera-
ture and is helpful to categorise implementation methods across
settings.
From the literature it is noted that screening is largely oppor-
tunistic in the Nigerian setting.26–29 The study authors noted that
women’s participation was poor and proffered different reasons
as towhy service uptakewas low. Reasons included poor demand
creation and weak information dissemination,26,27,29 low refer-
ral rates from general practitioners (GPs),27 low risk perception,
fear of getting a positive result26,28,32 and cultural barriers stem-
ming from the nature of the screening procedure, which involves
a pelvic exam.32 There is consensus among the authors that, al-
though there is no nationally organised programme in Nigeria,
opportunistic screening needs to be maximised.
Table 2 provides information on cervical cancer screening pro-
gramme activities in the four Nordic countries of interest.
It is noted that Denmark, Sweden and Finland implement or-
ganised screening.10,41 Norway, however, implements both op-
portunistic and organised screening activities at a fee.10
Common denominators in the four Nordic screening
programmes are:10,31
1. Long-term population-based screening;
2. Specified target populations with country-specific screening
intervals;
3. Invitations to eligible women through the screening registries;
4. Quality improvement processes that are overseen by working
groups or similar national bodies;
5. Regular data collection with well-established national
databases and national cancer registries.
Sweden and Finland have the longest running cervical can-
cer programmes in the world, both of which started in the
1960s.41 Sweden expanded organised screening to 69% with
overall screening coverage (including opportunistic screening)
at 82% after intensifying efforts to issue invitations for screen-
ing.35,39 In Denmark, it was noted that organised screening had a
more preventive effect compared with opportunistic screening as
they attribute a 3% decrease in incidence from the late 1980s to
the early 1990s to the introduction of organised screening over
that period.37 The Finnish organised programme is said to have
contributed to a 70–80% decrease in the age-adjusted cervical
cancer incidence,42 which was also the case in Norway, where a
22% decrease was noted after changes were made to improve
coordination in their screening programme.38 Additionally, both
the Finnish and the Norwegian organised screening programmes
were reported to be cheaper and more cost-effective.36,38
Availability of services at rural and urban health facilities
Screening services in Nigeria are providedmainly in urban tertiary
and secondary facilities.26,32 Most of the screening that occurs is
due to the presence of symptoms suggestive of cervical abnor-
mality.29 In Sweden and Finland, trained midwives collect sam-
ples at local maternity centres and send them to reference lab-
oratorys for assay.35,42 In Norway and Denmark, when women
receive their invitation letters for screening, it states that they are
due for a pap smear and should visit their current GP or gynae-
cologist.37,38
Effect of targeted interventions on participation and
service uptake
Six articles focused on the effect of interventions onwomen’s up-
take of screening services, with the locations of these studies be-
ing in Denmark, Sweden and Nigeria (Table 3).
The trial in Sweden reported that there was no significant dif-
ference between the control group that was required to pay a fee
for screening and the intervention group that had the fee abol-
ished.33 The authors suggest that other interventions for improv-
ing participationmight bemore effective, such as those thatwere
offered to both the intervention and control groups in this study
(namely, targeted individualised communication and education,
rescheduling of screening online and annual re-invitations sent to
non-attendees), which were thought to have led to the observed
increase in attendance noted across both groups during the study
period.33
The Danish study authors concluded that screening coverage
and participation can be increased by using a special targeted in-
vitation to non-attendees combined with increasing GPs’ atten-
tion to the programme.34
Within Nigerian settings, researchers studied strategies such
as free screening, cost subsidies and other incentives to improve
participation and coverage as part of the intervention.26,27,30 For
example, Okeke et al. used a lottery system to determine who
would get free screening and possible treatment if screened
positive; they found that women who received cancer treat-
ment subsidies were four percentage points more likely to take
up screening than those in the control group (a 30% relative
increase).
All the other studies that specifically addressed user fees
found that there was no significant change in uptake either
through removal of the fee or by reducing the amount, as ob-
served in the randomised intervention in Sweden.
The collective evidence supports the conclusion of Okeke
et al. that the optimal set of subsidies to increase service uptake in
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Table 3. Description of targeted interventions across three countries
Country; paper Intervention Findings
Sweden; Alfonzo
(2016)33
Women who were to be invited for screening were
randomised 1:1, to receive an invitation either
stating that the test was free (intervention
group) or that it cost 100 SEK (control group)
Researchers discovered no significant differences
between women who were charged and those offered
free screening (RR 0.93; 95% CI 0.85 to 1.02). There
were also no variances within the districts, age and
attendance after the most recent previous invitation or
previous experience of smear-taking
Denmark; Jensen
(2009)34
Normal letter at 3 y intervals to all women + a
specific targeted letter to non-attendees + GP
received visit by facilitators/advocates
The decline in non-attendees was 0.87% after 9 mo in
favour of the intervention. A difference of 0.94% in the
change of coverage rate was observed at 6 mo, which
increased to 1.97% at 9 mo in favour of the
intervention
Nigeria; Okeke
(2013)32
1. Scratch cards offered to women to provide
screening at N0, N50 (US$0.33) and N100
(US$0.66)
Women who were randomly selected to receive the
conditional cancer treatment subsidy were about 4%
more likely to accept cervical cancer screening
2. Lottery tickets for treatment subsidies
Nigeria; Obi
(2007)27
The intervention was described as a ‘highly
subsidised’ screening programme in Enugu. The
nature of the subsidy was not described
Authors report poor participation as <1% (932 women)
of the target population were reached
Nigeria; Adepoju
(2016)26
Free cervical cancer screening programme
sponsored by the Osun State government
Uptake of cervical cancer screening was low
Nigeria; Bassey
(2008)30
In the period under study, screening was free of
charge at three selected hospitals in Uyo
The study reports poor participation of the target
population as only 332 women participated in the 5 y
when free monthly screening was offered
developing countries must include subsidies towards treatment
costs in addition to price subsidies for screening.32
Discussion
Summary of findings
This review aimed to explore the current state of cervical cancer
prevention strategies in Nigeria and contrast this with evidence-
based interventions thatwere implemented in someNordic coun-
tries that have experienced a decline in cervical cancer incidence.
We sought to ascertain methods of implementation, the impact
of interventions designed to increase screening uptake and other
factors limiting or contributing to success.
We find in this review that cervical screening services in Nigeria
are mainly located in urban secondary and tertiary health cen-
tres. This contrasts sharply with the service delivery model used
in Sweden and Finland, where healthcare workers in local mater-
nity centres have the capacity to collect pap smears. It may also
explain the good coverage rates, especially in Sweden where av-
erage coverage is 82% across all counties, although we cannot
ascertain which counties are in rural areas.
We also found that the implementation of screening in Nige-
ria is opportunistic with evidence suggesting that opportuni-
ties are not fully maximised by caregivers.20,28,29 When review-
ing the evidence, we found that organised screening was rec-
ommended over opportunistic screening because it was the
deemed to be a more successful means of achieving full cov-
erage. It is also touted to be cheaper and more cost-effective
in the long run. In three of the four Nordic countries reviewed,
mostly it is organised screening that is implemented, with the
fourth country (Norway) implementing both organised and op-
portunistic programmes. Still, variations exist in implementa-
tion, with areas of overlap between opportunistic and organ-
ised strategies in all four countries.43 It is important to note that
these countries all made changes to move towards organised
screening; for example, in Sweden, active steps were taken to
homogenise their programme, which was believed to improve
coverage.35 Other advantages of organised screening include
reduced healthcare costs, universal coverage and social inequal-
ities, and improved registration and monitoring.41 However, op-
portunistic testing leads more directly to treatment where dis-
ease is found; also planning, preparation and completion of an
organised implementation process requires a long timeframeand
extensive resources.41 Bearing this in mind, it is important to ac-
knowledge what is possible in each setting, given differences in
resources and health system structures.
Studies specifically addressing user fees found that there was
no significant change in uptake attributed to either abolishing or
reducing a fee.
The four Nordic countries of interest use an invitational
method for encouraging women to attend testing. Women are
expected to have at least 9–12 screening tests in their lifetimes,
depending on the screening interval of 3–5 y. It is noted that cov-
erage is better in countries that invite all women targeted, and
not only women who did not attend screening.41
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Strengths and limitations
This review was conducted using a systematic approach: data
were extracted by one reviewer (HIA) while a senior researcher
(AMF) had oversight over limits and selection criteria. This review
greatly benefitted from good coverage of databases provided by
the LSHTM Library. Another strength was our search for grey liter-
ature in addition to academic literature. The start date limit was
set to the year 2000, to keep the search focused on the last 2
decades of cervical cancer screening programmes, although this
was likely a key reason why more articles about the early pro-
grammes in Nordic countries were not included in the review. Due
to translation resource limitations, we only searched for papers
in English, which is likely to have had a negligible impact in terms
of the Nigerian studies since English is the lingua franca in Nige-
ria, but we may have missed papers written in Finnish, Danish,
Norwegian or Swedish. Reassuringly, our strategy and criteria led
to the inclusion of the expected landmark studies related to the
subject matter.32,44
Initial database searches were undertaken in June/July 2018.
To ensure that no more recent publications were missed, we re-
ran searches in October/November 2019 to yield the most up-
to-date data. Another key strength was that grey literature was
included in the search and identified additional resources for the
review.
We synthesised the literature successfully despite the hetero-
geneity of the populations, study designs, outcome measures
and findings. Few studies provided population-level data or cervi-
cal cancer statistics collected at central registries, which limited
the extent of more complex analyses of incidence or prevalence
rates that could be conducted.We also had difficulty ascertaining
the coverage and impact of screening programmes in the Nige-
rian setting. Although there were some quality issues with four of
the studies,26–28,30 the data extracted from these were in align-
ment with those extracted from other sources.
Wenoted differences inwhat countries considered nationwide
population-based screening; there were overlaps in opportunistic
regional screening and national organised screening in the Nordic
countries. Despite these limitations clear themes arose and these
are developed below as recommendations.
Recommendations
The Nordic cervical screening programmes have spanned 50 y
and survived changes in government, shifts in sociocultural and
economic ebbs and flows that occur naturally over time. Our find-
ings suggest that the Nordic programmes have thrived because
national screening policies were enforced by law or by official rec-
ommendation with vital stakeholders at the helm of overseeing
policy transformed to practice.31,35 Sustainability and continuity
are inherentwhen programmes are country-led and driven by key
actors and stakeholders rather than time-bound, donor-driven
activities, as commonly found in Nigeria,45 which may end upon
a stipulated project close-out date.
The Nigerian National Cancer Control Policy, developed for im-
plementation from 2018 to 2022, highlights breast cancer and
cervical cancer as the cause of 50% of all cancer deaths in
country.46 It also notes ‘the absence of well-coordinated na-
tional screening programmes…significantly contributing to late
presentation of most cancer patients’.46 We, therefore, recom-
mend an evaluation and review of the current cancer policy im-
plementation in Nigeria, with an aim to prioritise the top cancers
that cause mortality and institute a working group composed of
key state actors and stakeholders to oversee policy implementa-
tion and evaluate progress.
Findings suggest the need, across both settings, for an effec-
tive monitoring and evaluation system to track key performance
indicators such as coverage and incidence.39 Also, the detailed
and consistent monitoring and evaluation of programme qual-
ity improvement processes provides a reliable evidence base for
prioritisation and evaluation of improvement strategies. There-
fore, we recommend not just a system for monitoring and eval-
uation of programme data with key performance indicators to
track programme impact but also amonitoring and evaluation of
programme quality improvement processes to inform activities
geared towards prioritisation of improvements.
In Nigeria, where major health services are centralised in ur-
ban tertiary facilities, a foremost concern should be decentrali-
sation of services. The Nigerian National Cancer 2018–2022 con-
trol plan has, as one of its objectives, to ensure that 40% of all
healthcare facilities (at primary, secondary and tertiary levels) are
strengthened through increased institutional capacity to deliver
cancer screening/early detection.46 This idea is not original as it is
one of the hallmarks of success in the Nigerian HIV programme;
there was a move from a vertical to a more integrated, provider-
initiated service provision47,48 with decentralisation from tertiary
to secondary and primary health facilities.49 This can serve as a
blueprint for the Nigerian cervical cancer programme.
Although all the Nordic countries moved to homogenise their
programmes to be organised, ‘opportunistic testing leads more
directly to treatment where disease is found; also planning,
preparation and completion of an organised implementation
process requires a long timeframe and extensive resources’.41
Therefore, we acknowledge the differences in resources and
health system structures in these two settings and recommend
that opportunistic screening be maximised in Nigeria by engag-
ing health workers to offer services, active referrals and client ed-
ucation by caregivers, while considering other effective ways to
improve screening coverage. It is also important to include the
‘screen and treat’ option,where cytology-based tests are not pos-
sible, as treatment can be provided in a single visit where neces-
sary. It is also believed to be amore low-cost and low-technology
method, especially when considering implemention in rural set-
tings.40
The evidence suggests that reducing or removing fees alone
is insufficient to improve women’s participation in cervical can-
cer screening initiatives in Nigeria, yet there are claims that the
biggest barrier to healthcare access in Nigeria is finance,20 hence
we cannot simply disregard the usefulness of interventions that
provide screening free of charge or at a subsidised rate. Pri-
oritised programmes in Nigeria, like those for Malaria and HIV
that are heavily subsidised by the government and donors, have
achieved appreciable levels of success owing to this support.50–53
Evidence from the Swedish trial33 included in our review shows
that health education and individualised communication can im-
prove screening coverage. This is also supported by a review
that examined health education interventions across developed
and developing countries, showing that they boosted screening
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coverage.54 Therefore, we do not discount the alleviating effect
of subsidy; rather, we suggest that, in addition to offering screen-
ing free of charge or offering subsidies for screening alone, con-
sideration should be given to a more complex package that may
include health education interventions, individualised communi-
cation, treatment subsidies in the event of a positive screening
outcome32 and other means of incentivisation such as payment
vouchers or prepayment schemes.20
The invitational system used in the four Nordic countries, to in-
vite all women targeted, requires cancer screening registries with
information databases. This may not currently be feasible in the
Nigerian setting, owing to lack of cancer registries, but there are
existing structures that can be leveraged, such as the biannual
Maternal, Newborn, Child Health Week, which is used to reach
large numbers of the women in this defined target group. Cov-
erage can be ascertained using available and extrapolated data
to estimate population size. We also suggest initial pilots that can
lead to scale-up so that lessons learnt can be documented and
improvements made iteratively during expansion. This was the
case in Finland, where pilots first started within the area of three
municipalities in 1963 and thenwere extendedwithin a few years
to most parts of the country.36
While HPV vaccination will be important in further reducing in-
cidence, beyond screening alone, there are numerous barriers to
uptake as, to date, the HPV immunisation rate is only 1% in low-
andmiddle-income countries.6 Hence, we see our recommenda-
tions as robust for the short to medium term.
Conclusions
A more successful approach for Nigeria, in addition to providing
subsidised or free screening programmes, would include country-
led action driven by state actors and key stakeholders to en-
sure continuity and sustainability of targeted interventions. Key
interventions geared towards improving uptake could comprise
incentivisation of treatment if screened positive and active en-
gagement of health workers for demand creation. Additionally,
well-defined policies that guide service provision are needed,
alongside a population-based approach to implementation (in-
cluding rural populations), and an effectivemonitoring and evalu-
ation of programme data for quality improvement of programme
delivery with a plan for continuous research and development in
cervical cancer programming.
Supplementary data
Supplementary data are available at International Health online.
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